Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Neuroblastoma”

209 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 209 results

Early research (Phase 1)Study completedNCT00005835
What this trial is testing

N99-02: Melphalan and Buthionine Sulfoximine

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 31
Testing effectiveness (Phase 2)Ended earlyNCT00969722
What this trial is testing

MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients

Who this might be right for
Primary Refractory Neuroblastoma
United Therapeutics 1
Testing effectiveness (Phase 2)Study completedNCT00135135
What this trial is testing

Therapy for Children With Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 23
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)UnknownNCT02771743
What this trial is testing

Response-based Treatment of High-risk Neuroblastoma

Who this might be right for
Newly Diagnosed High Risk Neuroblastoma
Samsung Medical Center 54
Large-scale testing (Phase 3)Study completedNCT01156142
What this trial is testing

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
Alliance for Clinical Trials in Oncology 155
Early research (Phase 1)Ended earlyNCT00053950
What this trial is testing

Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaRecurrent Neuroblastoma
National Cancer Institute (NCI) 42
Early research (Phase 1)Looking for participantsNCT06485947
What this trial is testing

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

Who this might be right for
Neuroblastoma
Princess Maxima Center for Pediatric Oncology 38
Early research (Phase 1)Study completedNCT00005978
What this trial is testing

N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Post-approval studies (Phase 4)Not Yet RecruitingNCT06047535
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Who this might be right for
Neuroblastoma
SciClone Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT00006102
What this trial is testing

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Study completedNCT00793351
What this trial is testing

Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation

Who this might be right for
Neuroblastoma
Samsung Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00793845
What this trial is testing

Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma

Who this might be right for
Neuroblastoma
Samsung Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT02169609
What this trial is testing

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

Who this might be right for
NeuroblastomaNeoplasm, ResidualEffects of Immunotherapy
Fundació Sant Joan de Déu 24
Testing effectiveness (Phase 2)UnknownNCT00281905
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Looking for participantsNCT06528496
What this trial is testing

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Who this might be right for
High-risk NeuroblastomaNeuroblastomaChildhood Neuroblastoma
Memorial Sloan Kettering Cancer Center 45
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Early research (Phase 1)Study completedNCT00070200
What this trial is testing

Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 31
Not applicableUnknownNCT00939965
What this trial is testing

Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group 75
Large-scale testing (Phase 3)Active Not RecruitingNCT02176967
What this trial is testing

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+1 more
Children's Oncology Group 621
Load More Results